Paraoxonase-1 Regulation of Renal Inflammation and Fibrosis in Chronic Kidney Disease
Papraoxonase-1 (PON1) is a hydrolytic lactonase enzyme that is synthesized in the liver and circulates attached to high-density lipoproteins (HDL). Clinical studies have demonstrated an association between diminished PON-1 and the progression of chronic kidney disease (CKD). However, whether decreas...
Saved in:
Main Authors: | Fatimah K. Khalaf (Author), Chrysan J. Mohammed (Author), Prabhatchandra Dube (Author), Jacob A. Connolly (Author), Apurva Lad (Author), Usman M. Ashraf (Author), Joshua D. Breidenbach (Author), Robin C. Su (Author), Andrew L. Kleinhenz (Author), Deepak Malhotra (Author), Amira F. Gohara (Author), Steven T. Haller (Author), David J. Kennedy (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A PON for All Seasons: Comparing Paraoxonase Enzyme Substrates, Activity and Action including the Role of PON3 in Health and Disease
by: Chrysan J. Mohammed, et al.
Published: (2022) -
Antioxidant Therapy Significantly Attenuates Hepatotoxicity following Low Dose Exposure to Microcystin-LR in a Murine Model of Diet-Induced Non-Alcoholic Fatty Liver Disease
by: Apurva Lad, et al.
Published: (2022) -
Paraoxonase/Arylesterase Activity of Serum Paraoxonase-1 and Schizophrenia: A Systematic Review and Meta-Analysis
by: Angelo Zinellu, et al.
Published: (2023) -
Paraoxonase 1 as an important antiatherogenic agent
by: Ewa Lidia Krzewicka-Romaniuk, et al.
Published: (2019) -
Paraoxonase 1 as an important antiatherogenic agent
by: Ewa Lidia Krzewicka-Romaniuk, et al.
Published: (2019)